Meta-analysis: Barrett's oesophagus and the risk of colonic tumours

Alimentary Pharmacology and Therapeutics

Volumn 37, Issue 4, 2013, Pages 401-410

  Andrici, J ^a   Tio, M ^a   Cox, M R ^a   Eslick, G D ^a  

^a NEPEAN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; COLON ADENOMA; COLON POLYP; COLON TUMOR; COLORECTAL CANCER; DISEASE ASSOCIATION; HUMAN; PREVALENCE; PRIORITY JOURNAL;

BARRETT ESOPHAGUS; COLONIC NEOPLASMS; HUMANS; RISK FACTORS;

EID: 84872682862     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12146     Document Type: Article

References (43)

1. Cameron AJ,. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997; 26: 487-94.
2. Engel LS, Chow WH, Vaughan TL, et al,. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003; 95: 1404-13.
3. Spechler JS,. Barrett's esophagus. N Engl J Med 2002; 346: 836-42.
4. Shaheen N, Ransohoff DF,. Gastroesophageal reflux. Barrett esophagus and esophageal cancer. JAMA 2002; 287: 1972-81.
5. Wang KK, Sampliner RE,. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 2008; 103: 788-97.
6. Sontag SJ, Chefjec G, Stanley MM, et al,. Barrett's Oesophagus and colonic tumours. Lancet 1985; 1: 946-9.
7. Howden CW, Hornung CA,. A systematic review of the association between Barrett's esophagus and colon neoplasms. Am J Gastroenterol 1995; 90: 1814-9.
8. Stroup DF, Berlin JA, Morton SC, et al,. Meta-analysis of Observational Studies in Epidemiology (MOOSE) Group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283: 2008-12.
9. Achkar JP, Post AB, Achkar E, Carey WD,. Risk of extraesophageal malignancy in patients with adenocarcinoma arising in Barrett's esophagus. Am J Gastroenterol 1995; 90: 39-43.
10. Bollschweiler E, Schloesser T, Leers J, Vallbohmer D, Schafer H, Holscher AH,. High prevalence of colonic polyps in white males with esophageal adenocarcinoma. Dis Colon Rectum 2009; 52: 299-304.
11. Lagergren J, Nyren O,. No association between colon cancer and adenocarcinoma of the oesophagus in a population based cohort study in Sweden. Gut 1999; 44: 819-21.
12. Vaughan TL, Kiemeney LA, McKnight B,. Colorectal cancer in patients with esophageal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4: 93-7.
13. Cook MB, Wild CP, Everett SM, et al,. Risk of mortality and cancer incidence in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2007; 16: 2090-6.
14. de Jonge PJF, van Blankenstein M, Looman CWN, Casparie MK, Meijer GA, Kuipers EJ,. Risk of colorectal cancer in patients with Barrett 's esophagus: a dutch population-based study. Am J Gastroenterol 2010; 105: 77-83.
15. Murphy SJ, Anderson LA, Mainie I, et al,. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's Oesophagus. Scand J Gastroenterol 2005; 40: 1449-53.
16. Poorman JC, Lieberman DA, Ippoliti AF, Weber LJ, Weinstein WM,. The prevalence of colonic neoplasia in patients with Barrett's esophagus: prospective assessment in patients 50-80 years old. Am J Gastroenterol 1997; 92: 592-6.
17. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
18. Elli L, Somalvico F, Rivolta R, Fregoni F,. Association between upper and lower gastrointestinal tract lesions. Dig Liver Dis 2010; 42S: S61-192.
19. Limburg PJ, Ahlquist DA, Talley NJ, Cameron AJ, Zinsmeister AR,. Risk and site predominance of colorectal cancer with Barrett's esophagus: a cohort study. Gastroenterology 1984; 106: A409.
20. Lyons MF, Tsuchida AM, Schlepp GE, Pearce WA, Peller TP,. Barrett's esophagus (BE) is associated with colon cancer compared to gastroesophageal reflux with stricture (GER/S). Gastroenterology 1993; 104: A139.
21. Rothstein RI, Smith RG, Power GC,. Barrett's esophagus and colonic neoplasia. Gastroenterology 1991; 100: A150.
22. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
23. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
24. Cauvin JM, Goldfain D, Le Rhun M, et al,. Multicentre prospective controlled study of Barrett's Oesophagus and colorectal adenomas. Lancet 1995; 346: 1391-4.
25. Gerson LB, Shetler K, Triadafilopoulos G,. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
26. Laitakari R, Laippala P, Isolauri J,. Barrett's Oesophagus in not a risk factor for colonic neoplasia: a case-control study. Ann Med 1995; 27: 499-502.
27. Robertson DAF, Ayres RCS, Smith CL,. Screening for colonic cancer in patients with Barrett's Oesophagus. Br Med J 1989; 298: 650.
28. Siersema PD, Yu S, Sahbaie P, et al,. Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc 2006; 63: 581-6.
29. Solaymani-Dodaran M, Logan RF, West J, Card T, Coupland C,. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's Oesophagus and gastro-oesophageal reflux. Scand J Gastroenterol 2004; 39: 680-5.
30. Post AB,. Re: Barrett's esophagus and colonic neoplasms. Am J Gastroenterol 1996; 91: 1056-7 (letter).
31. Logan RA, Skelly MM,. Barrett's Oesophagus and colorectal neoplasia: scope for screening? Gut 1999; 44: 775-6.
32. Levin B, Lieberman DA, McFarland B, et al,. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-95.
33. Smith RA, Cokkinides V, Eyre HJ,. American Cancer Society guidelines for the early detection of cancer, 2005. CA Cancer J Clin 2006; 56: 11-25.
34. El-Serag HB, Kvapil P, Hacken-Bitar J, Kramer JR,. Abdominal Obesity and the Risk of Barrett's Esophagus. Am J Gastroenterol 2005; 100: 2151-6.
35. Moghaddam AA, Woodward M, Huxley R,. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev 2007; 16: 2533-47.
36. Larsson SC, Wolk A,. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007; 86: 556-65.
37. Corley DA, Kubo A, Levin TR, et al,. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007; 133: 34-41.
38. Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL,. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007; 133: 403-11.
39. Butterworth AS, Higgins JPT, Pharoah P,. Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer 2006; 42: 216-27.
40. Castiglione G, Visioli CB, Zappa M, Grazzinib G, Mallardib B, Mantellinic P,. Familial risk of colorectal cancer in subjects attending an organised screening programme. Dig Liver Dis 2012; 44: 80-3.
41. Card TR, Solaymani-Dodaran M, Hubbard R, Logan RFA, West J,. Is an internal comparison better than using national data when estimating mortality in longitudinal studies? J Epidemiol Community Health 2006; 60: 819-21.
42. Elwood M,. Critical Appraisal of Epidemiological Studies and Clinical Trials. Oxford: Oxford University Press, 2007; 75-117.
43. Machin D,. Textbook of Clinical Trials. Chichester: John Wiley & Sons, 2006; 729-31.